Supporting addiction treatment makes cents
It’s been said many times, but it merits repeating: The U.S. is in the middle of an unprecedented drug crisis. According to a new report from the Ohio Department of Health, the number of opioid-related deaths leaped from 296 in 2003 to 2,590 in 2015 — a 775 per cent increase. Those statistics are repeated from coast to coast: The Centers for Disease Control and Prevention says that drug-overdose deaths involving heroin tripled from eight per cent in 2010 to 25 per cent in 2015.
That comes with a huge price tag: In Stark County, Ohio, the drug epidemic costs $75,000 a year in toxicology tests alone. And on March 10, the Stark County coroner’s office got a cold-storage trailer from the state to act as an overflow morgue.
Nationally, the Department of Health and Human Services estimates that in 2015, the opioid epidemic cost $55 billion in health and social services and $20 billion in emergency department and in-patient care for opioid poisonings.
As of this writing, the latest proposed health care bill ends the Affordable Care Act’s requirement that addiction services and mental health treatment be covered under Medicaid.
WHY WE SHOULD SUPPORT TREATMENT, ADDRESS CAUSE
One problem is that folks don’t understand addiction as a disease. It alters body biochemistry, just like any chronic disease does. Politicians and policy-makers evaluate the effectiveness of drug treatment programs using different standards from when thinking about treating an infection or managing diabetes.
If a person is given addiction treatment and relapses, many folks blame the addict. But if the same person were given an antibiotic for an infection and it didn’t knock the infection out with the first round, no one would say, “You just don’t have an immune system worth helping.”
HOW EFFECTIVE IS ADDICTION TREATMENT?
According to the National Institute of Drug Abuse, like other chronic diseases, addiction can be managed successfully. “Treatment enables people to counteract addiction’s powerful disruptive effects on the brain” and help addicts regain control of their lives. NIDA also points out that, “the chronic nature of the disease means that relapsing to drug abuse is not only possible but also likely, with symptom recurrence rates similar to those for other well-characterized chronic medical illnesses — such as diabetes, hypertension and asthma — that also have both physiological and behavioural components.”
Twenty to 50 per cent of Type 1 diabetes patients fail to control their diabetes at some time or another; 40 to 60 per cent of those who are addicted relapse; and 50 to 70 per cent of those with hypertension or asthma fail to control their disease consistently.
If someone “falls off the wagon,” that indicates treatments need to be reinstated or adjusted, or alternate treatment is needed.
The rewards are tangible. According to NIDA: “Every dollar invested in addiction treatment programs yields a return of between $4 and $7 in reduced drug-related crime, criminal justice costs and theft. When savings related to health care are included, total savings can exceed costs by a ratio of 12 to 1.”
Addiction is a chronic disease, and our society’s continued well-being and the well-being of sufferers depends on support for treatment.